<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Targeted Drug Delivery** **Explanation:** 1. **Lung Fibrosis Therapy:** Directly addresses the disease being treated (idiopathic pulmonary fibrosis/IPF). 2. **T &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/targeted-drug-delivery-explanation-1-lung-fibrosis-therapy-directly-addresses-the-disease-being-treated-idiopathic-pulmonary-fibrosis-ipf-2-t/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 14:25:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Targeted Drug Delivery** **Explanation:** 1. **Lung Fibrosis Therapy:** Directly addresses the disease being treated (idiopathic pulmonary fibrosis/IPF). 2. **T &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Nanosystem Targets TIMP-1 for Continuous Lung Fibrosis Therapy</title>
		<link>https://bioengineer.org/nanosystem-targets-timp-1-for-continuous-lung-fibrosis-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 14:24:54 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Based on the content and focus of the article]]></category>
		<category><![CDATA[Based on the content focusing on a novel nanosystem targeting TIMP-1 for continuous]]></category>
		<category><![CDATA[Continuous Drug Delivery]]></category>
		<category><![CDATA[here are 5 appropriate tags: **Lung Fibrosis Therapy]]></category>
		<category><![CDATA[here are 5 appropriate tags: **TIMP-1 targeted therapy]]></category>
		<category><![CDATA[idiopathic pulmonary fibrosis]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[Nanosystem drug delivery]]></category>
		<category><![CDATA[Spatiotemporal drug release]]></category>
		<category><![CDATA[spatiotemporally controlled therapy of idiopathic pulmonary fibrosis (IPF)]]></category>
		<category><![CDATA[Targeted Drug Delivery** **Explanation:** 1. **Lung Fibrosis Therapy:** Directly addresses the disease being treated (idiopathic pulmonary fibrosis/IPF). 2. **T]]></category>
		<category><![CDATA[TIMP-1 Targeting]]></category>
		<guid isPermaLink="false">https://bioengineer.org/nanosystem-targets-timp-1-for-continuous-lung-fibrosis-therapy/</guid>

					<description><![CDATA[In a groundbreaking leap forward for pulmonary medicine, a team of researchers led by Li, C., Lu, G., Chen, H., and colleagues has developed an innovative nanosystem designed to tackle idiopathic pulmonary fibrosis (IPF) through continuous spatiotemporal therapy. Published in Nature Communications in 2026, this pioneering study introduces a novel approach to delivering targeted treatment [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318368</post-id>	</item>
	</channel>
</rss>
